Jan. 25, 2018

Lupus Clinical Study

Open-Label Study Of Tofacitinib For Moderate To Severe Skin Involvement In Young Adults With Lupus

Researchers at Cincinnati Children’s Hospital Medical Center are looking for young adults age 18 to 45 that have skin lupus or SLE-CL to participate in the study of an investigational drug.  We want to evaluate the safety, tolerability and effectiveness of Tofacitinib to see if it helps young adults who have skin lesions associated with lupus. Participants will have about 21 study visits at Cincinnati Children’s Hospital Medical Center over a year and a half (76 weeks). Participants will take Tofacitinib twice a day, morning and evening, in pill form by mouth. If you are interested or have questions please contact Angela Merritt at Cincinnati Children’s .(JavaScript must be enabled to view this email address) or 513-803-2118.


For More information on the study, click the button below: